Organon & Co.
XNYS:OGN
| Market Cap (Intraday) | 3.61B |
| Current PE | 17.25 |
| Forward PE | 4.1 |
| 2yr Forward PE | 3.78 |
| 10-Day MA | $13.71 |
| 50-Day MA | $13.67 |
| 200-Day MA | $10.87 |
Organon & Co. Stock, XNYS:OGN
30 Hudson Street, 33rd floor, Jersey City, New Jersey 07302
United States of America
Phone: +1.551.430.6900
Number of Employees: 10000
Description
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women�s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.